Amedisys (AMED) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports Second Quarter 2017 Financial Results
July 26, 2017 5:00 PM EDTBATON ROUGE, La., July 26, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2017.
Three Month Periods Ended June 30, 2017 and 2016
Net service revenue increased $18.1Â million to $378.8Â million compared to $360.7Â million in 2016.Net income attributable to Amedisys, Inc. of $4.5Â million compared to $10.7Â million in 2016.Net income attributable to Amedisys, Inc. per diluted share of $0.13 compared to $0.32 in 2016.Adjusted Quarterly Results*
Adjusted EBITDA of $36.1Â million compared to $29.8Â million in 2016.Adjusted net service revenue of $378.8Â million compared to... More